Catalysts for Mekinist
43 tracked
Mar 26, 2026
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Mar 26, 2026
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Apr 21, 2025
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Apr 7, 2025
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Apr 7, 2025
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Mar 19, 2025
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Mar 19, 2025
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Mar 7, 2025
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Mar 7, 2025
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Jan 24, 2025
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jan 24, 2025
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Oct 1, 2024
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Oct 1, 2024
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Jul 11, 2024
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jul 11, 2024
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Mar 29, 2024
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Mar 29, 2024
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Feb 27, 2024
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Feb 27, 2024
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Aug 31, 2023
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
May 26, 2023
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Mar 16, 2023
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Mar 16, 2023
approval
MEKINIST (TRAMETINIB) — FDA approval
Spexotras
→
Jun 22, 2022
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
May 27, 2022
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jan 28, 2022
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jan 28, 2022
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Dec 3, 2021
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
May 7, 2021
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jun 23, 2020
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→